Myriad Genetics Inc. (MYGN)
NASDAQ: MYGN
· Real-Time Price · USD
4.93
-0.14 (-2.76%)
At close: Jun 20, 2025, 3:59 PM
4.92
-0.20%
After-hours: Jun 20, 2025, 05:45 PM EDT
-2.76% (1D)
| Bid | 4.78 |
| Market Cap | 454.43M |
| Revenue (ttm) | 823.6M |
| Net Income (ttm) | -116M |
| EPS (ttm) | -1.12 |
| PE Ratio (ttm) | -4.4 |
| Forward PE | 34.07 |
| Analyst | Hold |
| Ask | 5.5 |
| Volume | 933,869 |
| Avg. Volume (20D) | 2,213,140 |
| Open | 5.14 |
| Previous Close | 5.07 |
| Day's Range | 4.91 - 5.14 |
| 52-Week Range | 3.81 - 29.30 |
| Beta | 1.85 |
About MYGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MYGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MYGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Myriad Genetics Inc. is scheduled to release its earnings on Aug 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+9.42%
Myriad Genetics shares are trading higher. The com...
Unlock content with
Pro Subscription
2 weeks ago
+6.44%
Myriad Genetics shares are trading higher after the company announced new data from its MONSTAR-SCREEN 3 study.
3 weeks ago · accessnewswire.com
Levi & Korsinsky Investigates Myriad Genetics, Inc. (MYGN) Over Possible Securities FraudNEW YORK, NY / ACCESS Newswire / May 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. ("Myriad Genetics, Inc.") (NASDAQ:MYGN) concerning p...
